Skip to content

Clinical trials

Phase 3 Myelodysplastic Syndromes trials in Saudi Arabia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 3 Country / region: Saudi Arabia Clear all

3 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20151
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting1
Completed1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group1
Novartis Pharmaceuticals1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes3
Leukemia, Myelomonocytic, Chronic2
Myeloproliferative Disorders2
Anemia, Refractory1
Anemia, Refractory, with Excess of Blasts1
Burkitt Lymphoma1
Congenital Abnormalities1
Down Syndrome1
Graft vs Host Disease1
Hodgkin Disease1

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.